Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,056 | 47 | 95.0% |
| Education | $55.00 | 1 | 5.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $253.40 | 12 | $0 (2023) |
| Celgene Corporation | $175.12 | 6 | $0 (2019) |
| UCB, Inc. | $173.37 | 10 | $0 (2024) |
| PFIZER INC. | $136.65 | 2 | $0 (2018) |
| Amgen Inc. | $102.76 | 6 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $81.51 | 1 | $0 (2019) |
| GlaxoSmithKline, LLC. | $59.81 | 3 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $35.98 | 2 | $0 (2018) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $27.54 | 2 | $0 (2022) |
| Radius Health, Inc. | $19.28 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $112.60 | 6 | UCB, Inc. ($75.93) |
| 2023 | $119.41 | 5 | Janssen Biotech, Inc. ($68.50) |
| 2022 | $86.06 | 5 | Amgen Inc. ($37.73) |
| 2021 | $61.70 | 4 | UCB, Inc. ($31.37) |
| 2020 | $14.87 | 1 | UCB, Inc. ($14.87) |
| 2019 | $187.13 | 3 | Celgene Corporation ($105.62) |
| 2018 | $212.83 | 6 | PFIZER INC. ($121.38) |
| 2017 | $315.97 | 18 | Janssen Biotech, Inc. ($164.84) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/10/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Immunology | ||||||
| 07/10/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Immunology | ||||||
| 06/06/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Immunology | ||||||
| 05/07/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Immunology | ||||||
| 02/01/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Endocrinology | ||||||
| 01/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | CYLTEZO (Biological) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: CNS | ||||||
| 11/28/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Immunology | ||||||
| 08/23/2023 | Organon LLC | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 06/21/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Immunology | ||||||
| 03/30/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $55.00 | General |
| Category: Immunology | ||||||
| 03/16/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Immunology | ||||||
| 10/11/2022 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Immunology | ||||||
| 07/22/2022 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: Inflammation | ||||||
| 07/19/2022 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: IMMUNOLOGY | ||||||
| 04/07/2022 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Inflammation | ||||||
| 04/06/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Gastroenterology | ||||||
| 12/15/2021 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Inflammation | ||||||
| 08/26/2021 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: Immunology | ||||||
| 07/15/2021 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Immunology | ||||||
| 06/30/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: Gastroenterology | ||||||
| 04/28/2020 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Immunology | ||||||
| 09/17/2019 | Celgene Corporation | Otezla (Drug) | Food and Beverage | In-kind items and services | $84.75 | General |
| Category: Dermatology | ||||||
| 08/23/2019 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $81.51 | General |
| Category: Immunology | ||||||
| 05/29/2019 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $20.87 | General |
| 11/20/2018 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $17.41 | General |
About Dr. Reshma Banerjee-Kataria, DO
Dr. Reshma Banerjee-Kataria, DO is a Gastroenterology healthcare provider based in Wheelersburg, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053416305.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Reshma Banerjee-Kataria, DO has received a total of $1,111 in payments from pharmaceutical and medical device companies, with $112.60 received in 2024. These payments were reported across 48 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,056).
Practice Information
- Specialty Gastroenterology
- Location Wheelersburg, OH
- Active Since 09/13/2006
- Last Updated 07/28/2015
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1053416305
Products in Payments
- Cimzia (Drug) $173.37
- LYRICA (Drug) $136.65
- STELARA (Biological) $128.37
- Otezla (Drug) $106.95
- ORENCIA (Biological) $81.51
- TREMFYA (Drug) $68.50
- BENLYSTA (Biological) $59.81
- SIMPONI ARIA (Biological) $56.53
- Prolia (Biological) $46.86
- COSENTYX (Biological) $35.98
- Enbrel (Biological) $33.70
- TRULANCE (Drug) $27.54
- Tymlos (Drug) $19.28
- CYLTEZO (Biological) $17.39
- HADLIMA (Drug) $15.46
- Uloric (Drug) $12.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.